• ESCMID
  • CMI
  • EUCAST Newsletter
  • EUCAST News
Search
EUCAST
menu
Back Close
  • About EUCAST
    About EUCAST
    • Overview
    Close
    Organisation
    • Overview
    • Steering Committee
    • General Committee
    • EUCAST Statutes
    • National AST Committees (NAC)
    • Network Laboratories
    • Development Laboratories (EDL)
    • View all
    Subcommittees
    • Overview
    • Antimycobacterial Susceptibility Testing (AMST)
    • Antifungal Susceptibility Testing (AFST)
    • Veterinary Subcommittee on Antimicrobial Susceptibility Testing (VetCAST)
    • Phage Susceptibility Testing Subcommittee (PST)
    • Subcommittee on WGS and Phenotypic AST
    • View all
    Meetings
    • Overview
    • Steering Committee Meetings
    • General Committee Meetings
    Public Consultations
    • Overview
    SOPs
    • Overview
    IVDR and EUCAST
    • Overview
    News
    • Overview
    Publications and Presentations
    • Overview
  • Bacteria
    Bacteria
    • Overview
    Close
    Clinical Breakpoints and Interpretation
    • Overview
    • Clinical Breakpoint Tables
    • Definition of S, I and R
    • When there are no breakpoints?
    • Breakpoints in Brackets
    Guidance Documents
    • Overview
    Important Additional Information
    • Overview
    • Expert Rules
    • Expected Phenotypes
    • Resistance Detection
    MIC and Zone Distributions, ECOFFs
    • Overview
    Methodology and Instructions
    • Overview
    • Disk Diffusion and Quality Control
    • MIC Determination
    • Warnings
    • Media Preparation
    • Disk Diffusion Implementation
    • EUCAST Panels of Phenotypically Defined Strains
      • Overview
      • EUCAST Panel of S. pneumoniae and betalactam agents
      • EUCAST Panel of nine well characterized P. aeruginosa strains
    • IVDR and EUCAST
    • View all
    Rapid AST in blood culture
    • Overview
    • Rapid AST directly from blood culture bottles
    • Methods and Quality Control
    • Breakpoints for Rapid AST
    • Resistance Detection in RAST
    • RAST FAQ
    • RAST MIC:zone diameter correlations
    • RAST Publications
    • View all
    Development of Clinical Breakpoints and ECOFFs
    • Overview
    • About Clinical Breakpoints
    • Setting Breakpoints
    • Public Consultations
    • Rationale Documents
    • MIC:Zone Diameter correlations
    • Technical Notes on Antibacterial Agents
    • View all
    FAQ and EDL Services
    • Overview
    • FAQ
    • EDL MIC Testing Services
  • Mycobacteria (AMST)
    Mycobacteria (AMST)
    • Overview
    Close
    Subcommittee
    • Overview
    Clinical Breakpoints and Interpretation
    • Overview
    MIC distributions and ECOFFs
    • Overview
    Development of Clinical Breakpoints and ECOFFs
    • Overview
    • Public Consultations
    • Rationale Documents
    Methodology and Instructions
    • Overview
    • Reference Method
    • Mycobacteria FAQ
    • Warnings
    • IVDR and EUCAST
    Publications and Presentations
    • Overview
  • Fungi (AFST)
    Fungi (AFST)
    • Overview
    Close
    Subcommittee
    • Overview
    Clinical Breakpoints and Interpretation
    • Overview
    • Clinical breakpoint table
    • When there are no antifungal breakpoints
    Development of clinical breakpoints and ECOFFs
    • Overview
    • Rationale documents
    • Public consultations
    Methodology and Instructions
    • Overview
    • AST of Yeasts
    • AST of Moulds
    • AST of Dermatophytes
    • Warnings
    • Quality Control
    • IVDR and EUCAST
    • View all
    Publications and Presentations
    • Overview
    • Technical Notes on Antifungal Agents
  • VetCAST
    VetCAST
    • Overview
    Close
    Subcommittee
    • Overview
    MIC distributions and ECOFFs
    • Overview
    Development of clinical breakpoints and ECOFFs
    • Overview
    • Rationale Documents
    Publications and presentations
    • Overview
  • Industry
    Industry
    • Overview
    Close
  • Education
    Education
    • Overview
    Close
Search
  • ESCMID
  • CMI
  • EUCAST Newsletter
  • EUCAST News
Frequent searches
  • breakpoints
  • rationale documents
  • expected phenotypes
  • public consultation
  • endocarditis pathogens
  • guidance documents
Suggestions
  1. Home
  2. Search

Search Results

General

Reference MIC testing of Mycobacterium tuberculosis - discussion 9 Oct as followup to public consultation

On the 9th of October, 2024, from 14.00 - 16.00, CET, the EUCAST subcommittee on Anti-Mycobacterial Susceptibility Testin (AMST) will discuss and answer questions and comments raised during the public_consultation (March 1st - April 19th 2024) of the “EUCAST reference protocol for MIC determination…

Get to know more

Public consultation on breakpoints for Candida auris from the EUCAST AFST subcommittee

Public consultation on breakpoints for Candida auris 2025-03-06 - 04-17.

Get to know more

Consultations on B. melitensis and B.anthracis 1 Sept - 20 Oct

See public consultations on Brucella melitensis and Bacillus anthracis (1 Sept - 20 Oct).

Get to know more

Comments and responses to the consultation on pneumococci and viridans streptococci

EUCAST comments and responses to the public consultation on changing breakpoints for S. pneumoniae and Streptococcus viridans published.

Get to know more

Development of clinical breakpoints and ECOFFs

Development of clinical breakpoints and ECOFFs As with other breakpoints for antimicrobials the background for EUCAST breakpoints are given in Rationale Documents. Since for antifungals specific technical issues in testing may exist, technical notes are developed if needed. As with the general…

Get to know more

General consultation on proposed revision of chloramphenicol breakpoints

In a public consultation , EUCAST is asking for views on the proposed revision to chloramphenicol breakpoints. The last date for comments is 11 September, 2022.

Get to know more

Candida auris - comments to consultation and EUCAST AFST responses and actions

EUCAST AFST recently proposed new breakpoints for amphotericin B, three echinocandins and flucytosine against Candida auris . A public consultation was held 2025-03-06 - 2025-04-17. Now (2025-06-17) the EUCAST AFST has responded to comments .

Get to know more

Dosing in children

The European Society for Pediatric Infectious Disease ( ESPID ) has accepted an invitation from EUCAST to discuss dosing of antibiotics in children with specific reference to the EUCAST Dosing Table ( https://www.eucast.org/clinical_breakpoints/ ). EUCAST breakpoints, for both susceptible…

Get to know more

Is there a EUCAST alternative to MH-F for AST of fastidious organisms?

Susceptibility testing of fastidious organisms - is there an alternative to MH-F ? Public consultation 2025-06-19 - 08-29. The EUCAST medium MH-F was developed for AST of fastidious organisms.Colleagues in some areas of the world have difficulties obtaining the MH-F plate based on horse blood. The…

Get to know more

Fungi (AFST)

Fungi (AFST) The EUCAST AFST develops breakpoints and methods for antimicrobial susceptibility testing of fungi. Clinical breakpoints for fungi are listed in a separate document and are not included into the breakpoint table for bacteria. For MIC distributions for fungi, go to the EUCAST MIC…

Get to know more
Show more results
© EUCAST 2025. All rights reserved EUCAST.
ContactSitemapPrivacy NoticeDisclaimerCookies

Welcome to the new EUCAST website!

We’ve prepared a short video to help you get familiar with the new layout and features.

Watch the video here